BioLab Sciences announces patent for regenerative tissue therapy, MyOwn Skin™

In the United States alone, chronic wounds affect 6.5 million patients. Our advanced, tissue-biomanufacturing approach offers a viable, effective solution for skin regeneration and repair. This innovative strategy has shown to accelerate the healing of damaged soft tissue and improve wound-care outcomes.

Bob Maguire, Biolab Sciences CEO

Arizona-based biotech startup, BioLab Sciences, an innovator in regenerative medicine technologies, has recently announced a painless, non-surgical procedure, which utilises a patient’s own skin to produce full-thickness skin grafts in 5-7 days

MyOwn Skin™ aims to accelerate the healing of chronic wounds, burns, diabetic foot ulcers and other difficult-to-heal wounds. They claim that they can take a small skin sample, no bigger than a fingernail, and within about a week are able to three square patches of new skin, each measuring about 4×4 inchs. This will accelerate the wound repair and healing process by a matter of months.